With an aim to create awareness and build the capabilities of the Indian pharma sector to adopt global best manufacturing practices, the Indian Pharmaceutical Alliance (IPA) is organising the seventh Advanced Good Manufacturing Practices Workshop. The workshops will be conducted across three locations – Ahmedabad (10-11 October), Hyderabad (13-14 October) and Goa (17-18 October), with a line up of more than 20 expert speakers from the US Food and Drug Administration (FDA), World Health Organization (WHO), European Directorate for the Quality of Medicines (EDQM) and Healthcare, Central Drugs Standard Control Organisation (CDSCO), Parenteral Drug Association (PDA), regulators, global experts on quality and trade associations.
The first two-day workshop in Ahmedabad will commence with an inaugural address by Samir Mehta, President, IPA, followed by an opening address from Dr Sarah McMullen, Country Director, India Office, Office of Global Operations, US Food and Drug Administration (FDA) and a keynote address by Dr Hemant Koshia, FDCA Commissioner, Gujarat.
In the second workshop in Hyderabad, A Ramkishan, Deputy Drugs Controller, India (CDSCO) will deliver the keynote address. The series will end with a two-day workshop in Goa. The inaugural sessions will be followed by various informative sessions on investigation best practices, data integrity, digital data management, human error reductions, advancements in environmental monitoring and advancements in isolator technologies, among others.
The Advanced GMP workshop series is annually organised by IPA to provide an opportunity for manufacturers, regulators and Subject Matter Experts (SMEs) to deliberate and discuss ways to further manufacturing and quality excellence in the pharma industry. The workshops help improve the understanding on core issues such as quality management, global best practices and new technologies in manufacturing.